跳至主要内容
临床试验/NCT03329339
NCT03329339已完成不适用

1L Morning-only Polyethylene Glycol Plus Ascorbic Acid With Prepackaged Low-residue Diet Versus 2L Polyethylene Glycol Plus Ascorbic Acid for Bowel Preparation: a Randomized Trial

Seoul National University Bundang Hospital0 个研究点目标入组 200 人开始时间: 2015年5月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
200
主要终点
Achievement of preparation adequacy

研究概览

简要总结

Background 2L polyethylene glycol plus ascorbic acid (PEGA) is known to be as effective as standard 4L polyethylene glycol for bowel preparation. However, the volume of this regimen is still large. Therefore, the present investigators evaluated the potential of 1L PEGA with prepackaged low-residue diet (PLD) for an alternative to 2L PEGA.

Aim: To evaluate efficacy of 1L PEG with ascorbic acid combined with prepackaged low-residue diet as bowel preparation for colonoscopy.

Methods: The subjects were randomly assigned to either groups. PEGA group received 2L PEGA split regimen. PLD group received PLD on the day preceding colonoscopy and 1L PEGA on the morning of colonoscopy. One blinded physician performed colonoscopy and evaluated the degree of bowel preparation using Boston bowel preparation score (BBPS). A questionnaire regarding tolerability and safety were also gathered.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •anyone who were scheduled for an outpatient colonoscopy below indication
  • •patient who need colonic polyp screening
  • •patient who have hematochezia
  • •patient who have fecal occult blood test positive result

排除标准

  • •inflammatory bowel disease-
  • •gastrointestinal malignancy
  • •severe cardiac disease (heart failure beyond NYHA Class III)
  • •chronic obstructive pulmonary disease,
  • •decompensated liver cirrhosis; coagulopathy
  • •Female patients with pregnant or breastfeeding.
  • •who use long-term use of sedative, anti-spasmodic, prokinetic, laxative or anti-diarrheal medications

研究组 & 干预措施

2 L PEG with ascorbic acid group

No Intervention

1 L PEG with ascorbic acid with PLD

Experimental

干预措施: 1 L PEG with ascorbic acid with prepackaged, low residue diet (Procedure)

结局指标

主要结局

Achievement of preparation adequacy

时间窗: assessed at the colonoscopy day

Definition: Achievement of preparation adequacy was defined by as having BBPS scores of 2 or 3 for all colon segments. BBPS was measured by Physician who performing colonoscopy. To maintain precise evaluation, the physician participated in an online training program from www.cori.org/bbps. For each colon segment, BBPS preparation score ranged 0 to 3. Definition of BBPS are presented at www.cori.org/bbps

次要结局

  • Tolerability and adverse events(assessed at the colonoscopy day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyuk Yoon

Assistant professor

Seoul National University Bundang Hospital

相似试验